Related Experiment Video
Updated: May 24, 2025

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
Published on: October 16, 2015
Cross-species comparisons of plasma binding and considerations for data evaluation
Scott G Lynn1, Irvin R Schultz2, Sharlene R Matten3
1US Environmental Protection Agency, Office of Pesticide Programs, William Jefferson Clinton Building, 1200 Pennsylvania Avenue NW, Washington, DC 20460, USA.
This study used new approach methods (NAMs) to measure chemical binding in human, rat, and trout plasma. Results show differences in binding across species and highlight challenges with highly bound chemicals.
Area of Science:
- Environmental Science
- Toxicology
- Biochemistry
Background:
- The US Environmental Protection Agency (EPA) is adopting new approach methods (NAMs) for chemical safety assessments.
- In vitro methods like plasma binding assays are crucial for generating chemical-specific data.
Purpose of the Study:
- To present data from in vitro plasma binding experiments across human, rat, and rainbow trout.
- To evaluate the impact of physicochemical properties on chemical assay performance and facilitate cross-species comparisons.
Main Methods:
- Utilized rapid equilibrium dialysis (RED) with plasma from three species and 54 chemicals at two concentrations.
- Assessed data quality using mass balance controls for chemical stability and recovery.
- Analyzed correlations between fraction unbound in plasma (fup) and log Kow.
Main Results:
- Generated 238 chemical-species specific datasets, with 92 (approx. 40%) yielding quantitative measurements.
- Observed higher unbound fractions (fup) in rat plasma compared to human plasma.
- Found lower fup values in trout plasma than in rat or human plasma.
- Identified the strongest correlation between fup and log Kow for values between 1.5 and 4.
Conclusions:
- Chemicals with log Kow > 4.5 are highly bound, difficult to measure, and show low reproducibility.
- Robust data quality assessment is essential due to variable assay performance.
- Methodologies may need to be adapted based on chemical physicochemical properties, particularly for highly bound substances.
More Related Videos
15:27Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Published on: April 17, 2017
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Physiological Pharmacokinetic Models: Assumption with Protein Binding
The Equilibrium Binding Constant and Binding Strength
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...